Ms. Szyman

Ms. Szyman

Corporate Vice President, Critical CareatEdwards Lifesciences· In proxies 2023–2024

Pay in FY2024+27% from the year before

Ms. Szyman was paid $5.5M in FY2024 (Dec), up 27%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Edwards Lifesciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Edwards LifesciencesPublic company · 3 yr
    • Corporate Vice President, Critical Care2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?